Skip to main content

REPLACE (Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy): A look at Phase IV Study Data

Thank you

Thank you for joining us today. Industry Innovations Webinars are archived on the ATS YouTube channel under the Industry Innovation playlist.

Expect a brief satisfaction survey via email. Your feedback is appreciated as it helps improve programming for the future.


  • Dr. Richard Channick

    • Professor, David Geffen School of Medicine at UCLA
    • Director, Acute and Chronic Thromboembolic Disease Program
    • Co-Director, Pulmonary Vascular Disease Program at UCLA Medical Center

November 23, 2020
Mon 6:30 PM EST

Duration 1H 0M

This live web event has ended.